⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Nippon India Pharma Fund - Growth | TRUSTMF Small Cap Fund - IDCW - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | — | Trust MF |
| Category | Equity - Sectoral Fund - Pharma & Health Care | Equity - Small cap Fund |
| NAV | ₹560.30 (16 Sep 2026) | ₹13.66 (16 Sep 2026) |
| Rating | ★★★★ | ★★★ |
| Benchmark | BSE Health Care - TRI | Nifty Smallcap 250 - TRI |
| Fund Manager | Sailesh Raj Bhan | Mihir Vora |
| Inception | 05 Jun 2004 | 04 Nov 2024 |
| Returns | ||
| 1Y | 8.14% | 27.43% |
| 3Y | 16.46% | — |
| 5Y | 12.05% | — |
| Since Inception | 19.79% | 18.19% |
| Risk | ||
| 13.85 | 22.45 | |
| 0.92 | 0.94 | |
| 1.08 | 0.29 | |
| -0.64 | 11.41 | |
| 2.39 | 0.54 | |
| -10.45% | -15.49% | |
| Costs | ||
| Expense Ratio | 1.84% | 1.56% |
| Exit Load | 1% on or before 1M, Nil after 1M | 1% on or before 180D, Nil after 180D |
| Min SIP | ₹100 | ₹1,000 |
| Min Lumpsum | ₹5,000 | ₹1,000 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Nippon India …100%
Trust MF100%
0.0%Only 0.0% of holdings by weight are common between Nippon India Pharma Fund - Growth and Trust MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Category context: Equity vs Equity. Open the full Screener →